ClinicalTrials.Veeva

Menu

Excia T Cementless EBRA Study

Aesculap logo

Aesculap

Status

Withdrawn

Conditions

Hip Fractures
Arthritis, Degenerative
Femur Head Necrosis
Arthritis, Rheumatoid

Study type

Observational

Funder types

Industry

Identifiers

NCT02799654
AAG-O-H-1612

Details and patient eligibility

About

In this Post Market Clinical Follow-up Study (PMCF Study), the short-term clinical and radiological results of the cementless Excia T® prosthesis in routine clinical use shall be assessed and the migration taking place in the first 24 months evaluated.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written patient consent to study participation
  • Age > 18 years
  • Indication for primary THA with cementless Excia T® stem

Exclusion criteria

  • Pregnancy
  • THA after fracture
  • Rheumatoid arthritis
  • Systemic disorders, treated with Cortisone or other pharmaceuticals, potentially compromising the bone quality
  • Patient physically or mentally not able to follow the postoperative examination routine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems